Skip to main content
    N

    Nurix Therapeutics Inc (NRIX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $14.73
    -0.75 (-4.84%)

    Market Cap: $1.69B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nurix Therapeutics Inc (NRIX) Earnings: Report Dates and Results

    Updated Oct 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Nurix Therapeutics (NRIX) is expected to report earnings on Jan 26, 2027. In the quarter ended Aug 31, 2026, Nurix Therapeutics reported EPS of $4.73, above the -$0.56 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    48%(12/25)
    Avg Surprise
    +33.04%
    Streak
    1 Q

    Upcoming Estimates

    Reports Jan 26, 2027 (est.)Period ending Nov 30, 2026
    EPS Consensus-$0.50
    Range-$0.79 - $0.04
    16 analysts
    Revenue Consensus
    $36.08M
    Range$4.90M - $101.64M
    15 analysts
    Reports Apr 6, 2027 (est.)Period ending Feb 28, 2027
    EPS Consensus-$0.59
    Range-$0.59 - -$0.59
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.44-34.1%
    60d ago-$0.44-34.1%
    30d ago-$0.44-34.1%
    7d ago-$0.590.0%
    Current-$0.59
    Revenue Consensus
    $15.00M
    Range$15.00M - $15.00M
    1 analysts

    Next Report

    NRIX has an expected report date of Jan 26, 2027.

    Earnings History

    Of the 25 quarters below that had an estimate, NRIX beat 12 and missed 13. Revenue for the quarter ended Aug 31, 2026 was $673.06M, up 8430.5% from $7.89M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Aug 31, 2026$4.73-$0.56N/A+944.64%BeatN/A32 up, 0 downOct 12, 2026$673.06M
    May 31, 2026-$0.81-$0.73-$0.86 - -$0.50-10.96%MissN/A141 up, 1 downJul 9, 2026$9.04M
    Feb 28, 2026-$0.79-$0.83-$0.89 - -$0.65+4.76%BeatN/A125 up, 1 downApr 8, 2026$6.25M
    Nov 30, 2025-$0.82-$0.92-$1.15 - -$0.72+10.87%BeatN/A120 up, 0 downJan 28, 2026$13.58M
    Aug 31, 2025-$1.03-$0.85-$0.99 - -$0.68-21.18%MissN/A155 up, 10 downOct 9, 2025$7.89M
    May 31, 2025-$0.52-$0.74-$0.96 - -$0.60+29.73%BeatN/A151 up, 0 downJul 9, 2025$44.06M
    Feb 28, 2025-$0.67-$0.76-$0.89 - -$0.58+11.84%BeatN/A130 up, 6 downApr 8, 2025$18.45M
    Nov 30, 2024-$0.75-$0.67-$0.89 - -$0.54-12.12%MissN/A137 up, 2 downJan 28, 2025$13.28M
    Aug 31, 2024-$0.67-$0.68-$0.86 - -$0.60+1.47%BeatN/A120 up, 0 downOct 11, 2024$12.59M
    May 31, 2024-$0.71-$0.63-$0.85 - -$0.40-12.70%MissN/A123 up, 0 downJul 11, 2024$12.09M
    Feb 29, 2024-$0.76-$0.80-$0.95 - -$0.64+5.00%BeatN/A100 up, 0 downApr 10, 2024$16.59M
    Nov 30, 2023-$0.77-$0.50-$1.02 - $0.35-54.00%MissN/A111 up, 0 downFeb 15, 2024$15.16M
    Aug 31, 2023-$0.68-$0.74N/A+8.11%BeatN/A110 up, 0 downOct 12, 2023$18.47M
    May 31, 2023-$0.45-$0.57-$0.91 - -$0.39+21.05%BeatN/A100 up, 0 downJul 13, 2023$30.68M
    Feb 28, 2023-$0.75-$0.87-$1.00 - -$0.76+13.79%BeatN/A100 up, 0 downApr 13, 2023$12.69M
    Nov 30, 2022-$0.87-$0.79-$0.98 - -$0.29-10.13%MissN/A90 up, 0 downFeb 9, 2023$6.78M
    Aug 31, 2022-$0.90-$0.95-$1.14 - -$0.87+5.26%BeatN/A90 up, 0 downOct 6, 2022$10.79M
    May 31, 2022-$1.01-$0.99-$1.07 - -$0.94-2.02%MissN/A80 up, 0 downJul 7, 2022$11.43M
    Feb 28, 2022-$0.95-$0.89-$0.93 - -$0.77-6.74%MissN/A70 up, 0 downApr 7, 2022$9.62M
    Nov 30, 2021-$0.85-$0.69-$0.83 - -$0.37-23.19%MissN/A80 up, 0 downJan 27, 2022$7.40M
    Aug 31, 2021-$0.65-$0.62-$0.74 - -$0.47-4.84%MissN/A60 up, 0 downOct 14, 2021$10.25M
    May 31, 2021-$0.60-$0.56-$0.66 - -$0.39-7.14%MissN/A6N/AJul 13, 2021$7.09M
    Feb 28, 2021-$0.63-$0.45-$0.56 - -$0.34-40.00%MissN/A5N/AApr 13, 2021$5.01M
    Nov 30, 2020-$0.51-$0.54-$0.62 - -$0.42+5.56%BeatN/A5N/AFeb 16, 2021$6.69M
    Aug 31, 2020-$0.59-$0.45-$0.49 - -$0.31-31.11%MissN/A4N/AOct 14, 2020$4.08M
    May 31, 2020-$1.09N/AN/AN/AN/AN/AN/AN/AJul 24, 2020$4.18M
    Feb 29, 2020-$1.91N/AN/AN/AN/AN/AN/AN/AMay 5, 2020$2.86M
    Last 27 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Aug 31, 2026-$16.01N/A
    Nov 30, 2025-$3.04N/A
    Nov 30, 2024-$2.89N/A
    Nov 30, 2023-$2.65N/A
    Nov 30, 2022-$3.73N/A
    Nov 30, 2021-$2.73N/A
    Nov 30, 2020-$4.10N/A

    Frequently Asked Questions About NRIX

    When is Nurix Therapeutics's next earnings date?

    Nurix Therapeutics's next earnings report is expected for Jan 26, 2027.

    Did NRIX beat earnings estimates last quarter?

    Yes. Nurix Therapeutics reported EPS of $4.73 for the quarter ended Aug 31, 2026, above the -$0.56 estimate, a 944.64% surprise.

    What EPS do analysts expect from NRIX next quarter?

    The consensus EPS estimate for Nurix Therapeutics for the quarter ending Nov 30, 2026 is -$0.50 from 16 analysts, with estimates from -$0.79 to $0.04.

    How often does NRIX beat earnings estimates?

    Nurix Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +119.70%.